IMRN:NASDAQ
Immuron Ltd - ADR
$1.84
arrow_upward
+65.82%(+0.73) 1D
Sep 4, 9:36:41 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMRN...
Open
$1.82
High
$1.93
Low
$1.74
Mkt. cap
13.75M
Avg. vol.
16.61K
Volume
53.17M
52-wk high
$2.39
52-wk low
$0.68
EPS
-$0.54
Beta
1.17
Shares outstanding
8.07M
No. of employees
7
Open
$1.82
High
$1.93
Low
$1.74
Mkt. cap
13.75M
Avg. vol.
16.61K
Volume
53.17M
52-wk high
$2.39
52-wk low
$0.68
EPS
-$0.54
Beta
1.17
Shares outstanding
8.07M
No. of employees
7
News stories
From web sources and news partners
StocksToTrade
·
24 minutes ago
IMRN Stock Jumps As Immuron Beats Guidance And Advances Pipeline
Benzinga
·
30 minutes ago
Immuron Stock Surges Friday: What's Driving the Action?
www.timothysykes.com
·
1 hour ago
Immuron (IMRN) Jumps As Earnings Beat And Pipeline Progress Fuel Momentum
Benzinga
·
1 hour ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd - ADR
CEO-
Employees7
Founded1994
HeadquartersBlackburn North, Victoria, Australia
SectorBiotechnology
Websiteimmuron.com.au